CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-12 | Flynn James E 10% owner | Purchase | +25,000 | $14.00 | $350K | 255,764 |
| 2015-05-12 | Flynn James E 10% owner | Conversion · Series E Preferred Stock | −2,234,137 | 0 | ||
| 2015-05-12 | Flynn James E 10% owner | Conversion · Series E Preferred Stock | −2,234,137 | 0 | ||
| 2015-05-12 | DP VIII Associates, L.P. 10% owner | Conversion | +13,414 | 13,414 | ||
| 2015-05-12 | DP VIII Associates, L.P. 10% owner | Conversion · Series C Preferred Stock | −90,110 | 0 | ||
| 2015-05-12 | DP VIII Associates, L.P. 10% owner | Conversion · Series D Preferred Stock | −11,182 | 0 | ||
| 2015-05-12 | DP VIII Associates, L.P. 10% owner | Conversion · Series E Preferred Stock | −6,581 | 0 | ||
| 2015-05-12 | Domain Partners VIII, L.P. 10% owner | Conversion | +1,807,820 | 1,807,820 | ||
| 2015-05-12 | Domain Partners VIII, L.P. 10% owner | Conversion · Series C Preferred Stock | −12,143,933 | 0 | ||
| 2015-05-12 | Domain Partners VIII, L.P. 10% owner | Conversion · Series D Preferred Stock | −1,506,901 | 0 | ||
| 2015-05-12 | Domain Partners VIII, L.P. 10% owner | Conversion · Series E Preferred Stock | −887,073 | 0 | ||
| 2015-05-06 | Blackburn Stan See Remarks | Grant or award · Stock Option (right to buy) | +4,085 | 4,085 | ||
| 2015-05-06 | Chrzanowski Holly D. See Remarks | Grant or award · Stock Option (right to buy) | +11,943 | 11,943 | ||
| 2015-05-06 | Chereau Frederic President & COO | Grant or award · Stock Option (right to buy) | +22,001 | 22,001 | ||
| 2015-05-06 | Ramsdell Fred Vice President, Immunology | Grant or award · Stock Option (right to buy) | +17,600 | 17,600 | ||
| 2015-05-06 | Weiner David M. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +44,002 | 44,002 | ||
| 2015-05-06 | McKew John C. Vice President, Research | Grant or award · Stock Option (right to buy) | +25,144 | 25,144 | ||
| 2015-05-06 | Ashlock Melissa A. See Remarks | Grant or award · Stock Option (right to buy) | +25,144 | 25,144 | ||
| 2015-05-06 | Krueger Nancy See Remarks | Grant or award · Stock Option (right to buy) | +8,800 | 8,800 | ||
| 2015-05-06 | Blackburn Kelly See Remarks | Grant or award · Stock Option (right to buy) | +34,573 | 34,573 |
Page 24 of 25 · 483 trades